Cargando…
Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (LUAD) is one of the leading contributors to cancer‐related deaths worldwide. The objective of the current study is to identify a multidimensional transcriptome prognostic signature by combining protein‐coding gene (PCG) with long non‐coding RNA (lncRNA) for patients...
Autores principales: | Ye, Jing, Liu, Hui, Xu, Zhi‐Li, Zheng, Ling, Liu, Rong‐Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868416/ https://www.ncbi.nlm.nih.gov/pubmed/31402485 http://dx.doi.org/10.1002/jcla.22990 |
Ejemplares similares
-
Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung
por: He, Si-Yu, et al.
Publicado: (2019) -
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021) -
Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022) -
Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021) -
Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma
por: Zengin, Talip, et al.
Publicado: (2020)